AbbVie (NYSE: ABBV) today announced it will share new data at the European Hematology Association (EHA) 2026 Congress and will showcase clinical advancements from research programs across multiple… read more.
Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day,… read more.
Roche announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD). By… read more.
NICE (UK): Sotatercept, with other pulmonary arterial hypertension (PAH) treatments, can be used as an option to treat PAH in adults with World Health Organization functional class (WHO… read more.
Royal Philips announced regulatory clearance in the USA of Elevate Plus, bringing advanced imaging and a suite of AI and automation capabilities to Philips EPIQ Elite and Affiniti,… read more.
Amneal Pharmaceuticals announced that the FDA has approved the Company’s romidepsin injection solution, 27.5 mg/5.5 mL, supplied in single-dose, ready-to-use vials. The product is eligible for Competitive Generic… read more.
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued nineteen positive recommendations across two days in May 2026, covering a broad spectrum of… read more.
Cytokinetics, Incorporated announced the first commercial European launch of Myqorzo (aficamten) in Germany for the treatment of symptomatic (New York Heart Association, NYHA, class II-III) obstructive hypertrophic cardiomyopathy… read more.
The MHRA confirmed that it granted a UK marketing authorisation to Wayrilz (rilzabrutinib) for adults with immune thrombocytopenia (ITP) whose previous treatments have not worked sufficiently. The approval… read more.
BD (Becton, Dickinson and Company) announced the introduction of the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete BD’s kidney stone care portfolio… read more.
The National Institute for Health and Care Excellence (NICE) has issued six Technology Appraisal decisions between 6 and 20 May 2026, recommending four new treatments for NHS use… read more.
On 21 May 2026, the CHMP adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Wegovy. The marketing authorisation… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
